发布求助
文献互助 智能选刊 最新文献

Progress in Neurology and Psychiatry最新文献

筛选
英文 中文
Misdiagnosis of dementia with Lewy bodies due to venlafaxine 文拉法辛致路易体痴呆的误诊
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-04-01 DOI: 10.1002/pnp.742
M. Kanani, Nhishanth Gurunathan
{"title":"Misdiagnosis of dementia with Lewy bodies due to venlafaxine","authors":"M. Kanani, Nhishanth Gurunathan","doi":"10.1002/pnp.742","DOIUrl":"https://doi.org/10.1002/pnp.742","url":null,"abstract":"Dementia with Lewy bodies can be challenging to diagnose correctly and is subsequently underdiagnosed. Neuroimaging is often used to aid clinicians make the diagnosis. Here the authors describe a case where a patient was misdiagnosed with the condition due to their antidepressant therapy influencing their scan result.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48299985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Use of clozapine for psychosis and chorea in Huntington's disease systematic narrative review 氯氮平治疗亨廷顿舞蹈症中的精神病和舞蹈病系统叙述综述
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-04-01 DOI: 10.1002/pnp.750
Bethany Wildridge, S. Rozewicz, A. Mohamed, J. James, Gerard Connolly
{"title":"Use of clozapine for psychosis and chorea in Huntington's disease systematic narrative review","authors":"Bethany Wildridge, S. Rozewicz, A. Mohamed, J. James, Gerard Connolly","doi":"10.1002/pnp.750","DOIUrl":"https://doi.org/10.1002/pnp.750","url":null,"abstract":"The degenerative nature of Huntington's disease drastically reduces quality of life for sufferers while limiting life expectancy itself. Among other sequalae, psychosis and chorea remain persistently difficult disease manifestations to manage for patients. Clozapine is an atypical antipsychotic medication with a multineuroreceptor affinity, which gives it a broad range of action. Clozapine has been documented to have good remedial actions on chorea and psychosis in patients with Huntington's disease. Here the authors make the case for further research.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42439671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ponesimod for the treatment of relapsing‐remitting multiple sclerosis Ponesimod用于治疗复发缓解型多发性硬化症
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-04-01 DOI: 10.1002/pnp.745
T. Gaber, M. Eltemamy
{"title":"Ponesimod for the treatment of relapsing‐remitting multiple sclerosis","authors":"T. Gaber, M. Eltemamy","doi":"10.1002/pnp.745","DOIUrl":"https://doi.org/10.1002/pnp.745","url":null,"abstract":"Gone are the days when neurologists considering disease modifying therapy for their patients with relapsing remitting multiple sclerosis (RRMS) could only access a handful of agents that are easy to compare. This charmingly simple situation has rapidly evolved to an increased ability to access a variety of agents that are potentially suitable for the equally complex spectrum of RRMS syndromes with different clinical and radiological features. The approval of ponesimod by NICE as a first‐ or second‐line treatment for RRMS is another welcomed addition to the current agents available.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44008937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID‐19 in patients with Alzheimer's disease 阿尔茨海默病患者的新冠肺炎-19
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-04-01 DOI: 10.1002/pnp.748
A. A. Asadi-Pooya, Mohsen Farazdaghi, A. Emami, A. Akbari, F. Javanmardi
{"title":"COVID‐19 in patients with Alzheimer's disease","authors":"A. A. Asadi-Pooya, Mohsen Farazdaghi, A. Emami, A. Akbari, F. Javanmardi","doi":"10.1002/pnp.748","DOIUrl":"https://doi.org/10.1002/pnp.748","url":null,"abstract":"The link and association between COVID‐19 and Alzheimer's disease (AD) is controversial. This study aims to investigate whether COVID‐19 was associated with a different presenting clinical picture or a more severe course of illness (eg intubation and death) in people with AD in this study cohort.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49234574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Binge eating disorder and type 2 diabetes: epidemiology and treatment approaches 暴饮性饮食障碍与2型糖尿病的流行病学及治疗方法
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-04-01 DOI: 10.1002/pnp.749
A. Yahya, Shakil Khawaja, Paul Simon Williams, Meena Naguib
{"title":"Binge eating disorder and type 2 diabetes: epidemiology and treatment approaches","authors":"A. Yahya, Shakil Khawaja, Paul Simon Williams, Meena Naguib","doi":"10.1002/pnp.749","DOIUrl":"https://doi.org/10.1002/pnp.749","url":null,"abstract":"Binge eating disorder (BED) is the most common eating disorder in patients with type 2 diabetes (T2D) but remains underdiagnosed and undertreated. Here, the authors review the latest epidemiological findings and highlight the importance of early intervention and robust screening for BED in those with a diagnosis of T2D. The need for better‐quality studies that focus on the diagnosis, management and prognostic outcomes of BED in T2D is also revealed.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49402708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Self‐harm in an older adult population during the COVID‐19 pandemic COVID - 19大流行期间老年人的自我伤害
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-04-01 DOI: 10.1002/pnp.747
Michael Obidoa, R. Bello, S. Hardman
{"title":"Self‐harm in an older adult population during the COVID‐19 pandemic","authors":"Michael Obidoa, R. Bello, S. Hardman","doi":"10.1002/pnp.747","DOIUrl":"https://doi.org/10.1002/pnp.747","url":null,"abstract":"The COVID‐19 pandemic has presented major challenges for all demographics of society. The strict lockdown measures utilised to control the spread of the virus have the potential unintended consequences of exacerbating social isolation and loneliness, which are recognised to be pre‐existing issues in the elderly population. Because of this, the pandemic may have disproportionality impacted the elderly population. One way that the distress caused by the pandemic could manifest is through self‐harm and suicide. Here, the authors present a retrospective, cross‐sectional study examining self‐harm in an older adult population in the south west of England.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48273919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Changes in antibody titers and clinical course in myasthenia gravis retrospective study 重症肌无力患者抗体滴度和临床病程的变化回顾性研究
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-01-01 DOI: 10.1002/pnp.738
B. Berger, Nils Schröter
{"title":"Changes in antibody titers and clinical course in myasthenia gravis retrospective study","authors":"B. Berger, Nils Schröter","doi":"10.1002/pnp.738","DOIUrl":"https://doi.org/10.1002/pnp.738","url":null,"abstract":"Myasthenia gravis (MG) is a rare, long‐term autoimmune disorder that causes muscle weakness; the condition typically has phases when it remits and phases when it relapses. Even though treatment response with regards to immunosuppressive therapies in MG patients is classically monitored by clinical scores, identification of a serological biomarker that monitors treatment response could be helpful. Here, the authors explore the correlation between acetylcholine receptor (AChR) antibody titers with changes in clinical severity in patients with MG and discuss the implications for clinical practice.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46432360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
COVID‐19 and clozapine use in an early intervention for psychosis service COVID-19和氯氮平在精神病服务早期干预中的应用
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-01-01 DOI: 10.1002/pnp.737
Rizwana Jafry, Marlene Kelbrick
{"title":"COVID‐19 and clozapine use in an early intervention for psychosis service","authors":"Rizwana Jafry, Marlene Kelbrick","doi":"10.1002/pnp.737","DOIUrl":"https://doi.org/10.1002/pnp.737","url":null,"abstract":"Clozapine prescribing in treatment‐refractory schizophrenia is underutilised, including in early intervention for psychosis services. COVID‐19 has brought various challenges to the utilisation of clozapine, particularly in the context of initiation and monitoring. There is a need for clear national guidance in this regard.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47515174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Suicide in patients under care of first‐episode psychosis service 首次发作精神病服务护理下患者的自杀
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-01-01 DOI: 10.1002/pnp.739
A. Javed, D. Das
{"title":"Suicide in patients under care of first‐episode psychosis service","authors":"A. Javed, D. Das","doi":"10.1002/pnp.739","DOIUrl":"https://doi.org/10.1002/pnp.739","url":null,"abstract":"Recognition of suicide risk factors in patients presenting with psychotic illness is of the utmost importance. In their study, the authors identified two important issues in the cohort of patients who died of unnatural causes/suicide, highlighting a need for clinicians to be aware of these risk factors and make efforts to establish a therapeutic relationship, providing appropriate support to patients to help them to develop an awareness of their suicide risk and to empower them to resist their suicidal thoughts.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45747226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Seronegative autoimmune limbic encephalitis with psychiatric symptoms 伴有精神症状的血清阴性自身免疫性边缘脑炎
IF 1.2
Progress in Neurology and Psychiatry Pub Date : 2022-01-01 DOI: 10.1002/pnp.735
Shamim Asgari, Mbizvo Gashirai, Jennifer Smith, S. Alusi
{"title":"Seronegative autoimmune limbic encephalitis with psychiatric symptoms","authors":"Shamim Asgari, Mbizvo Gashirai, Jennifer Smith, S. Alusi","doi":"10.1002/pnp.735","DOIUrl":"https://doi.org/10.1002/pnp.735","url":null,"abstract":"Seronegative autoimmune limbic encephalitis is a rare clinical syndrome defined by a rapid onset of cognitive impairment with neuropsychiatric features and an absence of associated autoantibodies that often lead to diagnostic uncertainty, delayed treatment and ultimately, poor prognosis. Here a case is presented that highlights the benefits of implementing a multidisciplinary approach to treating the psychiatric manifestations, including a cautious use of therapeutic home leave for patients where the clinical course is prolonged.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47338047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信